Cargando…

Duloxetine in patients with diabetic peripheral neuropathic pain in Japan: a randomized, doubleblind, noninferiority comparative study with pregabalin

PURPOSE: Duloxetine and pregabalin are recommended as first-line treatments for diabetic peripheral neuropathic pain (DPNP). However, studies have not reported a direct comparison between duloxetine and pregabalin. We conducted a postmarketing, randomized, double-blind study to assess the noninferio...

Descripción completa

Detalles Bibliográficos
Autores principales:	Enomoto, Hiroyuki, Yasuda, Hitoshi, Nishiyori, Atsushi, Fujikoshi, Shinji, Furukawa, Masashi, Ishida, Mitsuhiro, Takahashi, Masashi, Tsuji, Toshinaga, Yoshikawa, Aki, Alev, Levent
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove Medical Press 2018
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6145353/ https://www.ncbi.nlm.nih.gov/pubmed/30271191 http://dx.doi.org/10.2147/JPR.S170646

Ejemplares similares

Duloxetine 60 mg for chronic low back pain: post hoc responder analysis of double-blind, placebo-controlled trials
por: Alev, Levent, et al.
Publicado: (2017)

Assessment of direct analgesic effect of duloxetine for chronic low back pain: post hoc path analysis of double-blind, placebo-controlled studies
por: Enomoto, Hiroyuki, et al.
Publicado: (2017)

Relationship Between Pain Alleviation and Disease-specific Health-related Quality of Life Measures in Patients With Chronic Low Back Pain Receiving Duloxetine: Exploratory Post Hoc Analysis of a Japanese Phase 3 Randomized Study
por: Enomoto, Hiroyuki, et al.
Publicado: (2019)

Duloxetine and pregabalin in neuropathic pain of lung cancer patients
por: Gül, Şule Karabulut, et al.
Publicado: (2020)

Correlation between pain response and improvements in patient-reported outcomes and health-related quality of life in duloxetine-treated patients with diabetic peripheral neuropathic pain
por: Ogawa, Kei, et al.
Publicado: (2015)

Relationship Between Pain Reduction and Improvement in Health-Related Quality of Life in Patients with Knee Pain Due to Osteoarthritis Receiving Duloxetine: Exploratory Post Hoc Analysis of a Japanese Phase 3 Randomized Study
por: Enomoto, Hiroyuki, et al.
Publicado: (2020)

An observational study of duloxetine versus SSRI monotherapy in Japanese patients with major depressive disorder: subgroup analyses of treatment effectiveness for pain, depressive symptoms, and quality of life
por: Kuga, Atsushi, et al.
Publicado: (2017)

An observational study of duloxetine versus SSRI monotherapy for the treatment of painful physical symptoms in Japanese patients with major depressive disorder: primary analysis
por: Kuga, Atsushi, et al.
Publicado: (2017)

A randomized, double-blind, placebo-controlled Phase III trial of duloxetine in Japanese patients with knee pain due to osteoarthritis
por: Uchio, Yuji, et al.
Publicado: (2018)

Safety and efficacy of duloxetine in Japanese patients with chronic knee pain due to osteoarthritis: an open-label, long-term, Phase III extension study
por: Uchio, Yuji, et al.
Publicado: (2018)

Analysis of HAM-D scores and working ability in an observational study of Japanese patients with major depressive disorder and painful physical symptoms treated with duloxetine or SSRI monotherapy
por: Kuga, Atsushi, et al.
Publicado: (2019)

Effect of duloxetine on neuropathic pain in patients intolerant to continuous administration of pregabalin
por: Shimada, Yohei, et al.
Publicado: (2017)

Response to duloxetine in chronic low back pain: exploratory post hoc analysis of a Japanese Phase III randomized study
por: Tsuji, Toshinaga, et al.
Publicado: (2017)

Meta-analysis of duloxetine vs. pregabalin and gabapentin in the treatment of diabetic peripheral neuropathic pain
por: Quilici, Sibilia, et al.
Publicado: (2009)

Pregabalin, the lidocaine plaster and duloxetine in patients with refractory neuropathic pain: a systematic review
por: Plested, Melanie, et al.
Publicado: (2010)

Predicting treatment outcomes of major depressive disorder by early improvement in painful physical symptoms: a pooled analysis of double-blind, placebo-controlled trials of duloxetine
por: Tokuoka, Hirofumi, et al.
Publicado: (2017)

Response to duloxetine in patients with knee pain due to osteoarthritis: an exploratory post hoc analysis of a Japanese Phase III randomized study
por: Itoh, Naohiro, et al.
Publicado: (2018)

A Prospective Observational Study Comparing the Efficacy and Safety of Duloxetine and Pregabalin in Diabetic Peripheral Neuropathic Pain
por: Shah, Islam, et al.
Publicado: (2022)

Comparison of amitriptyline supplemented with pregabalin, pregabalin supplemented with amitriptyline, and duloxetine supplemented with pregabalin for the treatment of diabetic peripheral neuropathic pain (OPTION-DM): a multicentre, double-blind, randomised crossover trial
por: Tesfaye, Solomon, et al.
Publicado: (2022)

Efficacy and safety of 40 mg or 60 mg duloxetine in Japanese adults with diabetic neuropathic pain: Results from a randomized, 52‐week, open‐label study
por: Yasuda, Hitoshi, et al.
Publicado: (2015)

Efficacy comparison of duloxetine and SSRIs at doses approved in Japan
por: Harada, Eiji, et al.
Publicado: (2015)

Efficacy and safety of duloxetine and Pregabalin in Iranian patients with diabetic peripheral neuropathic pain: a double-blind, randomized clinical trial
por: Joharchi, Khojasteh, et al.
Publicado: (2019)

Efficacy and Safety of a New Sustained-release Pregabalin Formulation Compared With Immediate-release Pregabalin in Patients With Peripheral Neuropathic Pain: A Randomized Noninferiority Phase 3 Trial
por: Han, Kyung Ah, et al.
Publicado: (2022)

The Clinical Relevance of Pain Severity Changes: Is There Any Difference Between Asian and Caucasian Patients With Osteoarthritis Pain?
por: Yue, Li, et al.
Publicado: (2019)

Correction to: Efficacy and safety of duloxetine and Pregabalin in Iranian patients with diabetic peripheral neuropathic pain: a double-blind, randomized clinical trial
por: Joharchi, Khojasteh, et al.
Publicado: (2019)

Comparison of the Efficacy of Duloxetine and Pregabalin in Pain Relief Associated with Diabetic Neuropathy
por: Shahid, Wajeeha, et al.
Publicado: (2019)

Duloxetine in the management of diabetic peripheral neuropathic pain
por: Ormseth, Michelle J, et al.
Publicado: (2011)

Pregabalin in Chemotherapy Induced Neuropathic Pain
por: Atreya, Shrikant
Publicado: (2016)

Morphine and pregabalin in the treatment of neuropathic pain
por: Wang, Yue, et al.
Publicado: (2017)

Evaluation of efficacy and safety of gabapentin, duloxetine, and pregabalin in patients with painful diabetic peripheral neuropathy
por: Devi, Padmini, et al.
Publicado: (2012)

Real-world comparison of health care utilization between duloxetine and pregabalin initiators with fibromyalgia
por: Peng, X, et al.
Publicado: (2014)

Patterns of health care utilization related to initiation of amitriptyline, duloxetine, gabapentin, or pregabalin in fibromyalgia
por: Kim, Seoyoung C, et al.
Publicado: (2015)

Therapeutic effects of diclofenac, pregabalin, and duloxetine on disuse-induced chronic musculoskeletal pain in rats
por: Ohmichi, Yusuke, et al.
Publicado: (2018)

Review of duloxetine in the management of diabetic peripheral neuropathic pain
por: Smith, Timothy, et al.
Publicado: (2007)

Pregabalin in Neuropathic Pain: Evidences and Possible Mechanisms
por: Verma, Vivek, et al.
Publicado: (2014)

Synergistic Antinociceptive Effects of Indomethacin–Pregabalin and Meloxicam–Pregabalin in Paclitaxel-Induced Neuropathic Pain
por: Ma, Yurong, et al.
Publicado: (2022)

Effectiveness of Duloxetine for Postsurgical Chronic Neuropathic Disorders after Spine and Spinal Cord Surgery
por: Tsuji, Osahiio, et al.
Publicado: (2021)

Randomized, Placebo-Controlled Comparison of Amitriptyline, Duloxetine, and Pregabalin in Patients With Chronic Diabetic Peripheral Neuropathic Pain: Impact on pain, polysomnographic sleep, daytime functioning, and quality of life
por: Boyle, Julia, et al.
Publicado: (2012)

The effect of pregabalin or duloxetine on arthritis pain: a clinical and mechanistic study in people with hand osteoarthritis
por: Sofat, Nidhi, et al.
Publicado: (2017)

Identification of Spinal Inhibitory Interneurons Required for Attenuating Effect of Duloxetine on Neuropathic Allodynia-like Signs in Rats
por: Ishibashi, Tadayuki, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_gb9vumq8lvmg59chrbftb05g58